Shilpa Medicare to expand bulk drug unit at Raichur in Karnataka with an investment of Rs. 218 million. The capacity of the project, after expansion will be 126.75 TPA. The expansion details of the new unit are as follows.
s. No. | Name of Products | Capacity (MTA) |
1 | Ambroxol HCI | 47 |
2 | Anastrozole | 0.1 |
3 | Bicalutamide | 0.5 |
4 | Carboplatin | 0.35 |
5 | Cisplatin | 0.1 |
6 | Coenzyme Q-10 | 18 |
7 | Docetaxel | 0.1 |
8 | Gemcitabine HCI | 0.3 |
9 | Irinotecan HCI Trihydrate | 0.1 |
10 | Oxaliplatin | 0.05 |
11 | Paclitaxel | 0.1 |
12 | Temozolomide | 0.1 |
13 | 3a, 7B-Dihydroxy Cholanic Acid | 60 |
Total | 126.8 |
11,950 ₹ | 4950 ₹ | 4950 ₹ | 4950 ₹ | 3950 ₹ |
Copyright © 2013 Ibis Research Information Services Pvt Ltd. All Rights Reserved.
Contact : Ibis Research Information Services Pvt Ltd., 28, Rajaji Street, NGO Colony
Guduvancherry, Chennai -603 202 Mobile : 0-97898-37940 email : [email protected] Privacy Policy